Silver Book Fact

Use of ACE inhibitor drugs for people with congestive heart failure helped avoid $9,000 per person in hospital costs over a 3-year period and reduced deaths by 16%.

SOLVD Investigators. Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure. N Engl J Med. 1991; 325(5): 293-302. http://content.nejm.org/cgi/content/abstract/325/5/293

Reference

Title
Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
Publication
N Engl J Med
Publication Date
1991
Authors
SOLVD Investigators
Volume & Issue
Volume 325, Issue 5
Pages
293-302
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Greater use of clot-busting drug t-PA in ischemic stroke patients could save the health care system over $100 million a year.  
  • Development and widespread use of left ventricular assist devices could result in a 50% decrease in heart failure-related hospitalizations.  
  • Data from clinical trials demostrate that ICDs reduce sudden cardiac death 5-10% per year for 2-3 years, compared to antiarrhythmic drugs.  
  • A recent data analysis of more than 2,700 stroke patients from the U.S. and Europe confirmed tPA’s effectiveness, which could save the U.S. nearly $50 million a year.  
  • Spending $1,000 per year on anticoagulants can save $100,000 in hospital costs for care of a person disabled by a stroke.